TY - JOUR
T1 - Corrigendum
T2 - Antimicrobial resistance in the COVID-19 landscape: is there an opportunity for anti-infective antibodies and antimicrobial peptides?(Front. Immunol., (2022), 13, (921483), 10.3389/fimmu.2022.921483)
AU - Pérez de la Lastra, José M.
AU - Anand, Uttpal
AU - González-Acosta, Sergio
AU - López, Manuel R.
AU - Dey, Abhijit
AU - Bontempi, Elza
AU - delaNuez, Antonio Morales
N1 - Publisher Copyright:
Copyright © 2024 Pérez de la Lastra, Anand, González-Acosta, López, Dey, Bontempi and delaNuez.
PY - 2024/1/1
Y1 - 2024/1/1
N2 - In the published article, there was an error in the affiliation information about Uttpal Anand [2]. Instead of “Department of Life Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel”, it should be “CytoGene Research & Development LLP, Uttar Pradesh, India”. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
AB - In the published article, there was an error in the affiliation information about Uttpal Anand [2]. Instead of “Department of Life Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel”, it should be “CytoGene Research & Development LLP, Uttar Pradesh, India”. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
KW - antibiotic discovery
KW - antibiotic resistance
KW - antimicrobial peptides
KW - environmental contamination
KW - global health
KW - one health approach
KW - SARS-CoV-2
KW - vaccination
UR - http://www.scopus.com/inward/record.url?scp=85184478500&partnerID=8YFLogxK
U2 - 10.3389/fimmu.2024.1365827
DO - 10.3389/fimmu.2024.1365827
M3 - Comment/debate
C2 - 38343533
AN - SCOPUS:85184478500
SN - 1664-3224
VL - 15
JO - Frontiers in Immunology
JF - Frontiers in Immunology
M1 - 1365827
ER -
